An opportunity for evidence-based care of individuals with monkeypox
BMJ Evid Based Med
.
2023 Jun;28(3):141-143.
doi: 10.1136/bmjebm-2022-112086.
Epub 2022 Dec 2.
Authors
Manuel Donato
1
2
,
Ariel Izcovich
3
,
Fernando Tortosa
3
4
,
Martin Alberto Ragusa
3
,
Carla Saenz
5
,
Ludovic Reveiz
3
Affiliations
1
National Commission for the Evaluation of Health Technologies (CONETEC), Ministry of Health, Buenos Aires, Argentina farmdonatomanuel@gmail.com.
2
Pharmacy service, Acute General Hospital José M. Penna, Buenos Aires, Argentina.
3
Evidence and Intelligence for Action in Health Department, Pan American Health Organization, Washington, District of Columbia, USA.
4
National University of Rio Negro, Viedma, Argentina.
5
Department of Health Systems and Services, Pan American Health Organization, Washington, District of Columbia, USA.
PMID:
36460327
PMCID:
PMC10314062
DOI:
10.1136/bmjebm-2022-112086
No abstract available
Keywords:
PUBLIC HEALTH; Pharmacy; Public health.
MeSH terms
Evidence-Based Medicine
Humans
Mpox (monkeypox)*